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Ginger as an effective anti-emetic 
agent for use in chemotherapy 
In silico analysis of the interactions of ginger actives 
with the serotonin (5-HT3) receptor 
Lohning, Anna E., Marx, Wolfgang
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Rationale
Marx, W., et al, Nutrients 2017, 9, 867 (Accepted August 2017)
• Clinical trials have shown preliminary support for the use of ginger in multiple 
types of nausea (motion, morning sickness, chemotherapy-induced) (Marx, 2013).
• Chemotherapy-induced nausea and vomiting (CINV) poses a major obstacle 
to patients (eg. treatment cessation). Variable responses to current 
treatments for CINV reduce their effectiveness in some patients providing 
impetus to develop more effective treatments (Hsieh, 2015).
• A key finding from a double-blinded, randomized-controlled trial (Marx, 2017) 
in chemotherapy-naïve patients was that intervention participants reported 
significantly better CINV-related quality of life (QoL) & less fatigue than placebo 
participants (Marx et al 2017).
Hsieh, R.K., et al, Support. Care Cancer 2015, 23, 263-272
Marx, W., et al, Nutr. Rev. 2013, 71, 245-254
Rationale    (cont’d)
• In conjunction with this on-going clinical research, our team are interested in 
mechanistic aspects of how ginger functions as an anti-emetic.
• In vitro studies have shown the active compounds in ginger
a) Inhibit serotonin-mediated signalling (possibly in a non-competitive manner)1
b) Inhibit serotonin (5-HT3)-induced contractions in guinea pig ileum
2
2 Abdel-Aziz,H. et al Planta Med. 71 (2005) 609–616.
• Current anti-emetic treatment for CINV (eg granisetron) target 5-HT3 receptors
• Understanding the details of how ginger actives bind and interact with this receptor 
will help guide rational drug design for more effective treatments.
1 Walstab, J.et al Neurogastroentereol. Motil., 25 (2013) 439-447 (e302); 
2 Pertz, J. et al Planta Med. 77 (10) (2011) 973–978
Introduction
• A primary pathway for emesis relating to CINV is stimulation of the vagal afferent 
nerves causing release of high levels of serotonin (5-HT3)
Stimuli includes luminal distension, parasympathetic innervation 
or changes in osmotic concentrations in intestinal contents.
• Current treatment for CINV involves use of 
anti-emetics (setrons) that competitively 
inhibit 5-HT3 receptors thus decreasing 5-
HT response.
ECCs
5-HT release
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• Serotonin binds to receptors on afferent nerves 
sending a signal to the central nervous system, 
mediating a range of physiological functions.
ECCs = enterochromaffin cells 
granisetronSerotonin
Introduction  (cont’d)
• The 5-HT3 subtype of serotonin receptors are 
cationic, pentameric ion channels. Other examples 
of this receptor type include GABA, glycine, nAch
receptors.
X-ray crystal structure of the 5-HT3 receptor 
(4pir.pdb) (Hassaine 2014) A (top); B (side)
• Functionally, the channel can be either open, 
closed or desensitized – serotonin binds with 
high affinity to the open channel.
• 5 distinct subunits (5-HT3A→E) leads to complexity 
of function. Other small molecules (Zn2+    ) effect 
functional state of receptor.
Introduction (cont’d)
• Since they were unable to displace 3HGR65630 (a competitive inhibitor) a non-
competitive mechanism was proposed (potential allosteric site) Similar findings 
were reported by Walstab in 2013.
Gingerols (n=6,8,10) Shogaols (n=6,8,10) Dehydoshogaols (n=6,8,10)
1 Ryan, J.L., et al Support. Care Cancer 2- (2012) 1479-1489.
2 Marx , W. et al Curr. Opin. Support, Paliat. Care 9(2) (2015) 189-195.
• Gingerols are the primary bioactives within the non-volatile, pungent component of 
the ginger rhizomes (Zingiber officinale).
• In vitro studies by Abdel Aziz in 2005 found that 6S, 6G, 8G and 10G inhibited 5-
HT3-induced contractions of the isolated guinea-pig ileum. 
• However the mechanism remains unclear1,2
Aims
2. To compare the theoretically-derived interaction energies with 
those obtained for serotonin and a range of 5-HT3 agonists 
and antagonists.
1. To use in silico techniques to determine whether a group of  
ginger actives could bind preferentially to the serotonin or an 
allosteric site of the mouse 5-HT3 receptor. 
Method:
Target preparation
• Homopentameric mouse 5-HT3 receptor 
(4pir.pdb) 
• Energy minimized (Gast-Hückel charges & H added)
• 2 subunits extracted for analysis 
(ECM/TM/ICD) *
• Both serotonin & allosteric sites are 
located at interface of two subunits 
(principle/complementary) with key 
interacting residues from both subunits 
(APAC) extracted
* SYBYLx2.1.1 molecular modelling software
Method
Ligand database preparation
Ligand Type
Serotonin, (5-HT)
6,8,10-G
6,8,10-S
6,8,10-DHSG
capsaicin, curcumin
granisetron, 
ondansetron, etc
PU02, bicurculline, etc
Acetylcholine, GABA 
* Energy minimization Protocol 
Forcefield Amber FF99
Charges Gasteiger-Huckel
Method Steepest Descent
Convergence 0.5 kcal/mol
• Structures obtained either from Pubchem/PDB databases or prepared in ChemDraw.
cognate ligand
Gingerols
Shogaols
Dehydroshogaols
Structural analogs of ginger actives 
Positive Controls (5-HT site) (Setrons) 
(competitive)
Positive Controls (allosteric 
site) (non-competitive)
Negative Controls (Decoys)
Method:
Molecular Docking (Surflex-Dock 2.1)
• Protomol method: Serotonin site (multi-channel) Allosteric site (residue-based)
• Partial Protein Flexibility docking approach (ligand AND protein atoms around site of interest). 
• Poses ranked according to Total Score (1/Kd) representing a theoretical binding affinity.
• C-score validation. Compares 4 scoring functions each with different weightings for non-bonded 
interactions)
Protomol area in serotonin site (A) and allosteric site (B)
Method (Cont’d)
2. GRID Analysis
topx,y,z
botx,y,z
GRID for serotonin site
Goodford, P. J. Med.Chem. 28 (7) (1985) 849–857.
3. Sequence Alignment
• Interaction energies calculated at each grid point (kcal/mol)  
(Goodford, 1985). 
• Grid box (dimensions (topx,y,z; botx,y,z)) generated around each 
site. (0.33 Å resolution)
• A set of small atomic/molecular probes was selected to mimic 
the chemical properties of key functional groups of the ligands.
• ClustalOmega alignment between mouse and human 5-
HT3 receptor sequences was performed to identify the 
degree of homology and identify conservation of residues 
likely to be important in ligand binding.
• Serotonin scored mid field in both sites (polar)
• Ginger compounds scored high in both sites (as did structural analogs (all amongst most hydrophobic)
• Competitive antagonists scored mid field at both sites (very similar clogPs)
• Polar non-competitive antagonists (NCAs) scored lowest in serotonon site. The more lipophilic NCAs scored higher in 
serotonin site. (Nb. allosteric modulators are more potent in heteromeric receptors)
• Decoys (highly polar) scored poorly in both sites. (Most polar scored mid range in allosteric site)
Results – Summary of Molecular Docking 
Sorted by clogP (high → low) Sorted by Total Score (sero) (high → low) Sorted by Total Score (allo) (high → low)
Polarity was a key factor for binding in serotonin site more than the allosteric site
Non-
polar
polar
Results – Molecular Docking 
• Connolly surface (top) depicts lipophilicity of 
receptor surface around serotonin site.
• Our results verify the lipophilic nature of site 
(orange contours (GRID 1.5 kcal/mol, strong 
interactions with hydrophobic probe)
• Serotonin (total score 5.7) and 10G (total 
score 10.81) docked into the serotonin binding 
site. 
• 10G docked into a location distinct and more 
hydrophobic than that of serotonin.
• Position of key residues forming ‘aromtic box’ 
(Y207, W156 P subunit; Y127, W63 C subunit) 
10-gingerol serotonin
Serotonin site
Results – Molecular Docking 
• Our results showed a positive correlation between ligand lipophilicity (clogP) 
and ligand flexibility and size.
• A cluster analysis showed ligands scored high that were :-
(1) flexible & hydrophobic (2) larger and hydrophobic
Serotonin site
Results – Molecular Docking 
Serotonin site
• Our results confirmed the importance of key residues thought to stabilise 
serotonin in this site, especially R65, N101, T154. 
• Our results identified novel interactions with  serotonin (D177, E173) and 
dolasetron (E209) and gingerols (K211, E209, L157)
• GRID successfully predicted position of aromatic ring of docked ginger actives.
PS
CS
Granisetron (atom  colours)  ondasetron;  
dolasetron;  romasetron;  palonosetron
Results – Molecular Docking 
• Experimental IC50 data (where 
available) included for comparison 
with docking scores for highest 
binding pose/ligand.
• Capsaicin (structural analog) scored 
highest followed by gingerol
compounds in allosteric site
• Serotonin site – total scores ranged 
from 4.25-10.81 (-logKD)
• Allosteric site – total scores ranged 
from 3.94-9.23 (-logKD)
Residues in blue (previously suggested by Hassaine to be important for stabilising serotonin
• 10G scored highest (ginger actives & 
structural analogs scored highly)
Results – Molecular Docking 
• The setron family of anti-emetics ranked mid-
field at both sites
• Cscores were high for 10G indicating a 
consensus between scoring functions for their 
overall ranking.
• Cscores were similarly high for serotonin, some 
setrons & non-competitive ligands. 
• Non-competitive ligands scored poorly as did 
decoys. (Nb. Allosteric ligands are more potent 
towards heteromeric targets)
Results: Molecular Docking
Allosteric site
Allosteric modulation permits fine-tuning of ion permeation via signal dampening.
The larger volume allows gingerols to adopt a more extended conformation facilitating favourable 
hydrophobic interactions with the transmembrane region.
Picrotoxin (NCA) is 
able to differentiate 
between A & B 
subunits1.
1 Thompson, A.J. et al Trends Pharmacol. Sci. (2013) 34(2), 100-109
Results: Molecular Docking
Allosteric site
Top  scoring  ligand,  capsaicin. Ginger actives also score well.
This site was found to be less hydrophobic compared to the serotonin site. 
(A):  GRID  contours  for  a  hydrophobic  
probe  (-0.5  kcal/mol). 
(B):  water  probe  (–11  kcal/mol) 
coincides with polar groups
Connolly  surface  coloured  by  lipophilic  character
• Ginger actives ranked highly.
Gingerols > shogaols > DHSGs
• Order correlates with the higher 
polarity of the site.
• Unlike serotonin site, polarity was not 
the key determinant contributing to 
score
• Eg. PU02 (clogP similar to ginger actives) 
scored low)
Results: Molecular Docking
Allosteric site
Key Finding:
Flexibility and hydrogen bonding capacity played a key role in binding interaction
Superimposition of 6G, 8G and 10G
Sequence alignment (ClustalOmega)
• subunits A and B of the mouse & human 5-HT3 receptors
Results:
B human
A mouse
A human
B mouse
• Key residues highlighted for :-
• principle  subunit  (blue shaded  box)
• complementary  subunit  (grey  shaded  box)
• pore-facing  residues  of  TM2  (red  star *)
• TM  regions  M1-M4  (underlined).  
FASTA colouring scheme (based on residue type)
Key Finding:
All residues required for stabilising ginger compounds in both 
sites were conserved between mouse & human 
• Results show human & mouse 5-HT3A share ~85% 
sequence homology while 5-HT3B share ~73%. Human A 
& B subunits share only ~44%.
Limitations
• Species differences 
• Functional State
• Subunit Composition
• Transmembrane/ECM interface - another potential binding site
• Inherent in Molecular Docking approaches are
• Inaccuracies in the energy models used to score potential ligand/receptor 
complexes
• The inability of current methods to account for conformational changes 
that occur during the binding process not only for the ligand, but also for 
the receptor (ie. how to cope with protein flexibility (1000’s of degrees of 
freedom)
• The above can be alleviated by using the more robust, Molecular 
Dynamics (full protein flexibility) – see later.
Conclusions / Future Directions
Key Findings
• Serotonin bound to a site distinct from other ligands in serotonin site.
• Ligand hydrophobicity directly correlated to higher scoring in serotonin site while 
ligand flexibility and hydrogen bonding capacity facilitated more potent interactions at 
the allosteric site.
• Our results were in agreeance with a number of key residues involved in stabilising 
serotonin (R65, N101 & T154) at the orthogonal site. Novel residues (E102 & R219) 
could be exploited in drug design.
• At allosteric site, novel residues, R219, Q56, F222, Q53 and I139 were important in 
stabilising ginger actives.
• Ginger compounds scored highly in both sites. 
• Structural characteristics (flexibility, hydrophobicity, Hbond acceptors/donors) enable them to 
exploit complementary features in a binding pocket. Similar dual roles have been observed.
Conclusions / Future Directions
Future Work in Progress
Clinical  A larger clinical trial has been accepted for funding (NHMRC, Feb 2017).
Mechanistic  Validation of docking results is currently being carried out to confirm 
stability of ligands at each site using molecular dynamics simulations (GROMACS). 
Analytical analysis
Quantification of ginger actives was conducted in a range of commercial ginger 
products to determine (Marx et al (2016) 
Preliminary MD Data
10 ns Molecular Dynamics (MD) simulation of 
serotonin in 5-HT3 receptor (ECD) in explicit solvent
Protocol
(Gromacs 5.04)
Forcefield – gromos54a7
EM, NVT NPT (Berendson
thermostat/barostat), 
Neighbour coupling (Verlet) 
E’statics (Reaction-field)
MD – 10ns; 2 fs timestep.
VMD Trajectory.
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